Quality teams track a lot of numbers. Kits shipped, members contacted, campaigns launched. But only one number actually moves a HEDIS measure: the return rate. A gap does not close when a kit ships. It closes when the member completes the test and the result comes back. Everything else is activity, not outcome.
Reaching the members who are behind on screening is difficult by definition. They are often the hardest to engage: they may have moved, changed numbers, faced language barriers, or simply learned to tune out generic outreach. A program that ships kits without a serious engagement engine tends to see low completion, and low completion means the gap stays open.
Return rate responds to engagement that is designed for the population, not bolted on. That means multilingual, omni-channel outreach across text, phone, email, and mail, sequenced and timed to the way members actually respond, with opt-in and opt-out handled respectfully. It means kits that are simple to use, with a member support line for anyone who gets stuck, and prepaid return so nothing stands between the member and completion.
Done well, this works. SNT Biotech's engagement model drives an average at-home kit return rate above 24 percent for a Medicaid health plan, well above program norms. Commercial populations typically return at even higher rates. Behind each completed kit is audit-ready documentation, so the closure holds up under review.
When you evaluate an at-home screening partner, look past the activity metrics and ask one question: what return rate do you actually drive, and can you document it? That single number, more than any other, determines whether your investment turns into closed gaps and improved Star performance.
See how our engagement model reaches the members your program has struggled to move.